Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase I data reported for GDC-3280 in healthy subjects

Aug. 23, 2021

FDA clears IND for clinical trials of siroquine for newly diagnosed GBM

Aug. 23, 2021

Bavarian Nordic studies ABNCoV2 as COVID-19 booster vaccine in phase II

Aug. 23, 2021

ACMT reports on patients becoming ill from use of ivermectin for COVID-19

Aug. 23, 2021

AAV gene therapy targeting CaMKII protects retinal ganglion cells, preserves vision

Aug. 23, 2021

Improved serum metabolic profile and symptoms in patients with ALS treated with ILB

Aug. 23, 2021

Salicylanilide compounds show promise for treating COVID-19

Aug. 23, 2021

APP gene mutation causes autosomal dominant Alzheimer's disease

Aug. 23, 2021

KIN-001 for COVID-19 shows preclinical antiviral, anti-inflammatory and antifibrotic activity

Aug. 23, 2021

Shanghai Bowei Biological Technology, collaborators divulge polynucleotides for expressing HPV 51L1

Aug. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...